Century Therapeutics (IPSC) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Century Therapeutics (IPSC) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Century Therapeutics

· IPSC

Dashboard

Financials

Ratios

Valuation

Statistics

309.639 M

-0.00%

General

Market Cap: $309.64M
Enterprise Value: $276.52M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -38.25%
ROE: -52.76%
ROIC: -43.66%
Current Ratio: 8.28
Debt-to-Equity: 0.15
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 1.25
EV/EBITDA: -2.91

Growth

Rev 1Y: 1556.76%
Rev 1Y Fwd Est: -95.67%
Rev 3Y (CAGR): 175.88%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $93.27M
Operating Income: -$118.8M
Net Profit: -$109.79M

Balance Sheet

Cash and Equivalents: $49.64M
Working Capital: $109.7M
Total Assets: $287.01M
Net Debt: -$15.02M
Total Liabilities: $54.66M
Total Equity: $232.35M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$86.74M
Cash Flow from Investing: -$47.82M
Cash Flow from Financing: $126.99M
Free Cash Flow: -$88.53M
Capital Expenditures: $1.79M